Recent Announcements

PhotoPharmics Innovations Address Global Health Inequalities

Innovation not only brings improved treatments to address large, unmet medical needs but can also improve access for underserved patient populations. PhotoPharmics today announced its intent to leverage its Breakthrough Device designation, CMS’s MCIT rule, and global delivery channels to deliver its treatments for Parkinson’s and neurodegenerative diseases to individuals regardless of their location or income.

The strength of the Company’s phase 2 data encouraged FDA to grant Breakthrough Device designation (details here) for its home-based, non-invasive therapeutic device in Parkinson’s. This designation speeds FDA’s review process for devices that provide for more effective treatment for life-threatening or irreversibly debilitating diseases.

read more

Media Contact

Brett Walker


Additional News


The importance of good diet and nutrition for people with Parkinson’s

We wanted to take a closer look at the effects of good nutrition on people with Parkinson’s disease. And thankfully for us there was a lot of great information out there. The effects of a good diet on Parkinson’s disease is a subject that has been covered extensively by researchers, scientists and advocacy groups. Read more >

The benefits of being outside for people with Parkinson’s​

One of the things we love most about this time of year is that it allows us to start getting outside again into the warm and sunny weather. But are there any benefits to being outside for people with Parkinson’s? Read more >

Survey highlights eagerness for Parkinson’s disease breakthrough discoveries

We at PhotoPharmics are passionate about representing the Parkinson’s community in an effort to raise awareness. In a recent survey, PhotoPharmics discovered a large percentage of people are waiting with great eagerness for breakthroughs that will improve the standard of care for people with Parkinson’s. Read more >

Social Media Activity


Ready to help people with Parkinson's get back to the things they love the most about life. Sign up to learn more about our upcoming phase 3 clinical trial:

#parkinsons #parkinsonsdisease

PhotoPharmics is a clinical-stage medical device company developing next-generation treatments for treating neurodegenerative disorders through the eyes.

Learn more about us at

Learn more about what it means to receive Breakthrough Device Designation from the @US_FDA

We're so proud that our phototherapy device has been given this incredible distinction!

#phototherapy #photopharmics #breakthrough


Specialized phototherapy may be the only treatment to significantly improve a broad range of non-motor symptoms and overall function in Parkinson's disease, on top of best managed care.Click the link in our bio to learn more! 👉 @photopharmics_...#parkinsonsdisease #parkinsons #phototherapy #photopharmics ... See MoreSee Less

3 hours ago  ·  

View on Facebook
We couldn't possibly let this special day go by without acknowledging the super moms in the Parkinson's community. Whether they are moms with Parkinson's disease, or moms who are acting as caregivers for someone they love with PD, there are some truly remarkable mothers in the world of Parkinson's. Happy Mother's Day to them and everyone!.Tag a Parkinson's mom to let them know how special they are!.#parkinsonsdisease #parkinsons #YOPD #mothersday #happymothersday #caregivers #parkinsonsawareness ... See MoreSee Less

1 day ago  ·  

View on Facebook
Over the past 20 years many short-term light therapy trials have demonstrated varying degrees of improvement in motor and non-motor symptoms in Parkinson’s disease. Building on this research, PhotoPharmics supported pilot trials to better understand the effects of various wavelengths, intensities, and session frequency of light administration..Our research yielded a light administration protocol and a combination of intensities and wavelengths and has led to our proprietary specialized phototherapy technology. Our specialized light therapy device is convenient and non-invasive and promises to be effective in improving motor and non-motor function and quality of life in Parkinson’s disease..Click the link in our bio to learn more! @photopharmics_ ... See MoreSee Less

3 days ago  ·  

View on Facebook